Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HHV4
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 107 | 109 | PF00675 | 0.543 |
CLV_NRD_NRD_1 | 117 | 119 | PF00675 | 0.410 |
CLV_NRD_NRD_1 | 133 | 135 | PF00675 | 0.688 |
CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.560 |
CLV_NRD_NRD_1 | 32 | 34 | PF00675 | 0.516 |
CLV_NRD_NRD_1 | 43 | 45 | PF00675 | 0.518 |
CLV_NRD_NRD_1 | 65 | 67 | PF00675 | 0.616 |
CLV_NRD_NRD_1 | 69 | 71 | PF00675 | 0.709 |
CLV_NRD_NRD_1 | 80 | 82 | PF00675 | 0.604 |
CLV_NRD_NRD_1 | 9 | 11 | PF00675 | 0.468 |
CLV_NRD_NRD_1 | 97 | 99 | PF00675 | 0.532 |
CLV_PCSK_FUR_1 | 115 | 119 | PF00082 | 0.406 |
CLV_PCSK_FUR_1 | 17 | 21 | PF00082 | 0.493 |
CLV_PCSK_FUR_1 | 29 | 33 | PF00082 | 0.446 |
CLV_PCSK_FUR_1 | 95 | 99 | PF00082 | 0.613 |
CLV_PCSK_KEX2_1 | 107 | 109 | PF00082 | 0.543 |
CLV_PCSK_KEX2_1 | 117 | 119 | PF00082 | 0.410 |
CLV_PCSK_KEX2_1 | 133 | 135 | PF00082 | 0.688 |
CLV_PCSK_KEX2_1 | 19 | 21 | PF00082 | 0.528 |
CLV_PCSK_KEX2_1 | 31 | 33 | PF00082 | 0.497 |
CLV_PCSK_KEX2_1 | 43 | 45 | PF00082 | 0.508 |
CLV_PCSK_KEX2_1 | 65 | 67 | PF00082 | 0.616 |
CLV_PCSK_KEX2_1 | 69 | 71 | PF00082 | 0.709 |
CLV_PCSK_KEX2_1 | 8 | 10 | PF00082 | 0.467 |
CLV_PCSK_KEX2_1 | 80 | 82 | PF00082 | 0.604 |
CLV_PCSK_KEX2_1 | 97 | 99 | PF00082 | 0.532 |
CLV_PCSK_PC7_1 | 65 | 71 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 85 | 89 | PF00082 | 0.564 |
DEG_APCC_DBOX_1 | 7 | 15 | PF00400 | 0.427 |
DOC_USP7_MATH_1 | 181 | 185 | PF00917 | 0.601 |
LIG_14-3-3_CanoR_1 | 44 | 54 | PF00244 | 0.513 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.387 |
LIG_BRCT_BRCA1_1 | 78 | 82 | PF00533 | 0.583 |
LIG_FHA_2 | 188 | 194 | PF00498 | 0.572 |
LIG_FHA_2 | 50 | 56 | PF00498 | 0.710 |
LIG_Integrin_RGD_1 | 72 | 74 | PF01839 | 0.504 |
LIG_LIR_Apic_2 | 36 | 42 | PF02991 | 0.585 |
LIG_Rb_pABgroove_1 | 9 | 17 | PF01858 | 0.341 |
LIG_SH2_CRK | 39 | 43 | PF00017 | 0.578 |
LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.509 |
LIG_TRAF2_1 | 190 | 193 | PF00917 | 0.569 |
MOD_CK1_1 | 76 | 82 | PF00069 | 0.483 |
MOD_CK1_1 | 91 | 97 | PF00069 | 0.427 |
MOD_CK2_1 | 187 | 193 | PF00069 | 0.583 |
MOD_CK2_1 | 49 | 55 | PF00069 | 0.513 |
MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.499 |
MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.581 |
MOD_GlcNHglycan | 90 | 93 | PF01048 | 0.445 |
MOD_GSK3_1 | 165 | 172 | PF00069 | 0.549 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.545 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.522 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.502 |
MOD_NEK2_1 | 139 | 144 | PF00069 | 0.649 |
MOD_NEK2_1 | 151 | 156 | PF00069 | 0.579 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.467 |
MOD_PIKK_1 | 59 | 65 | PF00454 | 0.558 |
MOD_PKA_1 | 20 | 26 | PF00069 | 0.500 |
MOD_PKA_1 | 80 | 86 | PF00069 | 0.545 |
MOD_PKA_2 | 139 | 145 | PF00069 | 0.738 |
MOD_PKA_2 | 165 | 171 | PF00069 | 0.556 |
MOD_PKA_2 | 175 | 181 | PF00069 | 0.532 |
MOD_PKA_2 | 20 | 26 | PF00069 | 0.503 |
MOD_PKA_2 | 80 | 86 | PF00069 | 0.696 |
MOD_PKA_2 | 88 | 94 | PF00069 | 0.688 |
MOD_Plk_1 | 37 | 43 | PF00069 | 0.440 |
TRG_ER_diArg_1 | 107 | 110 | PF00400 | 0.578 |
TRG_ER_diArg_1 | 115 | 118 | PF00400 | 0.424 |
TRG_ER_diArg_1 | 133 | 136 | PF00400 | 0.629 |
TRG_ER_diArg_1 | 137 | 140 | PF00400 | 0.525 |
TRG_ER_diArg_1 | 17 | 20 | PF00400 | 0.513 |
TRG_ER_diArg_1 | 29 | 32 | PF00400 | 0.473 |
TRG_ER_diArg_1 | 42 | 44 | PF00400 | 0.451 |
TRG_ER_diArg_1 | 51 | 54 | PF00400 | 0.513 |
TRG_ER_diArg_1 | 64 | 66 | PF00400 | 0.570 |
TRG_ER_diArg_1 | 68 | 70 | PF00400 | 0.588 |
TRG_ER_diArg_1 | 8 | 10 | PF00400 | 0.473 |
TRG_ER_diArg_1 | 80 | 82 | PF00400 | 0.616 |
TRG_ER_diArg_1 | 96 | 98 | PF00400 | 0.482 |
TRG_Pf-PMV_PEXEL_1 | 110 | 114 | PF00026 | 0.426 |
TRG_Pf-PMV_PEXEL_1 | 12 | 16 | PF00026 | 0.430 |
TRG_Pf-PMV_PEXEL_1 | 149 | 153 | PF00026 | 0.700 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S7X2W4 | Leishmania donovani | 61% | 89% |
A0A422N639 | Trypanosoma rangeli | 43% | 91% |
A4I504 | Leishmania infantum | 61% | 92% |
E9B0D4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 61% | 89% |
Q4Q7U6 | Leishmania major | 65% | 100% |